Prevalence of β-hemolytic Streptococcus in children with special health care needs.

Viviane Martha Santos de Morais, Alice Ramos Orsi, Fernanda Cristina de Albuquerque Maranhão, Therezita Maria Peixoto Patury Galvão Castro, Karina Cavalcante Beltrão de Castro, Denise Maria Wanderlei Silva
Author Information
  1. Viviane Martha Santos de Morais:  Department of Tropical Medicine, Federal University of Pernambuco.

Abstract

Pharyngotonsillitis by β-hemolytic Streptococcus mostly affects children and immunocompromised, being Streptococcus pyogenes (Group A) the most common agent in bacterial pharyngotonsillitis.
AIM: This work targeted the research of β-hemolytic Streptococcus Group-A (SBHGA) and No-A (SBHGNA) in the oropharynx of individuals with special health needs from the APAE (Maceió-AL).
METHOD: A prospective study with oropharynx samples from patients with Down syndrome and other mental disorders (test) and students from a private school (control) aged 5-15 years. Cultures in blood agar (5%) were identified through Gram/catalase tests and bacitracin/trimethoprim-sulfamethoxazole disk diffusion method, applying the chi-squared statistical analysis.
RESULTS: A total of 222 bacterial colonies were isolated in 74 individuals from APAE and 65 in the control group. In the test group, previous episodes of pharyngotonsillitis were reported by 36.49% (27/74) and 9.46% (7/74) were diagnosed with symptoms and/or signs suggestive of oropharynx infection. No positive sample of S. pyogenes was confirmed at APAE, being all samples classified as SBHGNA, with 5 SBHGA in the control group.
CONCLUSION: The early identification of β-hemolytic Streptococcus is important for the fast treatment of pharyngotonsillitis and the absence of S. pyogenes avoid future suppurative or not-suppurative sequels in the group from APAE.

References

Braz J Otorhinolaryngol. 2009 Jan-Feb;75(1):139-46 [PMID: 19488574]
Clin Infect Dis. 2002 Jul 15;35(2):113-25 [PMID: 12087516]
Medicina (B Aires). 2005;65(4):311-4 [PMID: 16193708]
Clin Exp Immunol. 2009 May;156(2):189-93 [PMID: 19250275]
Braz J Otorhinolaryngol. 2006 Sep-Oct;72(5):587-91 [PMID: 17221049]
Am Fam Physician. 2001 Apr 15;63(8):1557-64 [PMID: 11327431]
Yonsei Med J. 2004 Feb 29;45(1):56-60 [PMID: 15004869]
Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):423-33 [PMID: 21103900]
Clin Microbiol Rev. 2004 Jul;17(3):571-80, table of contents [PMID: 15258094]
Ann Clin Microbiol Antimicrob. 2012 Feb 02;11:3 [PMID: 22296671]
Pol J Microbiol. 2010;59(4):219-26 [PMID: 21466038]
J Nippon Med Sch. 2011;78(3):174-7 [PMID: 21720091]
Trends Microbiol. 2007 Jul;15(7):318-25 [PMID: 17524649]
Am Fam Physician. 2009 Mar 1;79(5):383-90 [PMID: 19275067]
Clin Microbiol Rev. 2000 Jul;13(3):470-511 [PMID: 10885988]
J Antimicrob Chemother. 2004 Aug;54(2):447-50 [PMID: 15269193]

MeSH Term

Anti-Bacterial Agents
Case-Control Studies
Child
Disk Diffusion Antimicrobial Tests
Female
Humans
Intellectual Disability
Male
Pharyngitis
Prevalence
Prospective Studies
Streptococcal Infections
Streptococcus pyogenes
Tonsillitis
Trimethoprim, Sulfamethoxazole Drug Combination

Chemicals

Anti-Bacterial Agents
Trimethoprim, Sulfamethoxazole Drug Combination

Word Cloud

Similar Articles

Cited By